563869 Mouse Anti-Human CD107a BV786,557832 Mouse Anti-Human CD3 APC Cy 7,566104 Mouse Anti-Human C
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Bid Publish Date
19-Jun-2025, 12:24 pm
Bid End Date
11-Jul-2025, 10:00 am
Location
Progress
Quantity
14
Category
FITC anti human IgD Antibody IA6 2 348206 100tests
Bid Type
Two Packet Bid
Indian Council Of Medical Research (icmr) has released a public tender for FITC anti human IgD Antibody IA6 2 348206 100tests, TCRgd PC7, CD3 APC UCHT1 1 Ml ASR, 560178 BD CD45 2D1 APC H7, PerCP by Cyanine5 5 anti human IgM Antibody BIOLEGEND, Hu CD38 BV605 HB7 100 Tst, Hu CD15 PerCP Cy5 5 HI98, Hu CD157 PE SY by 11B5, Hu CD107a FITC H4A3, CD56 APC NCAM16 2 in MUMBAI, MAHARASHTRA. Quantity: 14. Submission Deadline: 11-07-2025 10: 00: 00. Download documents and apply online.
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Directorate Of Purchase And Stores
MUMBAI, MAHARASHTRA
Indian Council Of Medical Research (icmr)
DIBRUGARH, ASSAM
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Directorate Of Purchase And Stores
MUMBAI, MAHARASHTRA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | FITC anti human IgD Antibody IA6 2 348206 100tests | FITC anti human IgD Antibody IA6 2 348206 100tests | 1 | pieces | icmrniih | 30 |
| 2 | TCRgd PC7 | TCRgd PC7 | 1 | pieces | icmrniih | 30 |
| 3 | CD3 APC UCHT1 1 Ml ASR | CD3 APC UCHT1 1 Ml ASR | 2 | pieces | icmrniih | 30 |
| 4 | 560178 BD CD45 2D1 APC H7 | 560178 BD CD45 2D1 APC H7 | 3 | pieces | icmrniih | 30 |
| 5 | PerCP by Cyanine5 5 anti human IgM Antibody BIOLEGEND | PerCP by Cyanine5 5 anti human IgM Antibody BIOLEGEND | 1 | pieces | icmrniih | 30 |
| 6 | Hu CD38 BV605 HB7 100 Tst | Hu CD38 BV605 HB7 100 Tst | 1 | pieces | icmrniih | 30 |
| 7 | Hu CD15 PerCP Cy5 5 HI98 | Hu CD15 PerCP Cy5 5 HI98 | 1 | pieces | icmrniih | 30 |
| 8 | Hu CD157 PE SY by 11B5 | Hu CD157 PE SY by 11B5 | 2 | pieces | icmrniih | 30 |
| 9 | Hu CD107a FITC H4A3 | Hu CD107a FITC H4A3 | 1 | pieces | icmrniih | 30 |
| 10 | CD56 APC NCAM16 2 | CD56 APC NCAM16 2 | 1 | pieces | icmrniih | 30 |
Experience Criteria
Certificate (Requested in ATC)
OEM Authorization Certificate
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ALLIANZ BIOINNOVATION Under PMA | - | 30-06-2025 18:09:39 | Evaluated |
| 2 | EXCELL BIOSOLUTIONS Under PMA | - | 10-07-2025 20:46:28 | Evaluated |
| 3 | GENEX LIFE SCIENCES PRIVATE LIMITED Under PMA | - | 28-06-2025 15:33:19 | Evaluated |
| 4 | LINK BIOTECH Under PMA | - | 10-07-2025 17:59:37 | Evaluated |
Please sign in or create an account to view contract details and download result documents.
Key insights about MAHARASHTRA tender market
The eligibility requirements include being a registered entity within India, possessing relevant experience in the supply of laboratory consumables, and adherence to specified technical and financial standards. It is imperative for bidders to demonstrate compliance with the Make in India initiative, not only supporting local production but also enhancing self-sufficiency in health sectors.
Bidders must provide relevant certificates that reflect compliance with industry quality standards, including those pertaining to safety and efficacy of the consumables. Products should hold certifications from recognized bodies that authenticate their reliability and compliance with required health regulations. This assures the authority of the quality and viability of the reagents and consumables provided.
The submission process involves several steps. Bidders need to prepare their proposals in the prescribed format as outlined in the tender document. This includes compiling the technical and financial bids along with necessary certifications. Submissions must be made electronically via specified channels and must include clear identifiers to facilitate proper handling during evaluation.
The Earnest Money Deposit (EMD) acts as a security to ensure bid commitment. Bidders must include this deposit as part of their submission, which is generally a specified percentage of the overall bid amount. Return conditions vary; generally, EMD amounts are returned post-award of tender or upon non-award outcomes.
Yes, this tender has specific provisions promoting participation from Micro, Small, and Medium Enterprises (MSEs) and startups. Such bidders may benefit from lower entry barriers, potential financial incentives, and increased opportunities targeting local production. These initiatives align with strategic goals of boosting local economies while complying with procurement norms which favor domestic ventures.
Sign up now to access all documents
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS